What Researchers Did
Researchers conducted a review to discuss the body's physiological responses to varying oxygen concentrations, from very low (hypoxia) to very high (hyperoxia). They explored oxygen's role as a medical treatment in extreme environments.
What They Found
The review found that while the biochemical effects of oxygen are well-characterized, a complete understanding of its pathophysiological impact is still developing. Preclinical models support the use of hypobaric hypoxia preconditioning for benefits like improved ventricular function. Oxygen is increasingly used for novel clinical indications such as healing diabetic foot ulcers and bone injury caused by radiotherapy, and is a pharmacological mediator for decompression sickness, osteonecrosis from radiotherapy, and sudden sensorineural hearing loss.
What This Means for Canadian Patients
This review highlights the potential of oxygen, including hyperbaric oxygen therapy (HBOT), for treating several conditions. Canadian patients with diabetic foot ulcers, bone damage from radiation (osteoradionecrosis), or decompression sickness may find these insights relevant to their treatment options.
Canadian Relevance
This study is not Canadian and does not have Canadian authors. However, it covers Health Canada-recognized indications for hyperbaric oxygen therapy, specifically diabetic foot ulcers, osteoradionecrosis, and decompression sickness.
Study Limitations
As a review, this study synthesizes existing literature and notes that the full pathophysiological characterization of cellular and tissue mediators related to oxygen modulation is still lacking.